Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene-Reference-Cited by-同舟云学术

Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene

Published:2019-07 Issue:30 Volume:37 Page:4089-4093
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Beissbarth Jemima^ORCID,Smith-Vaughan Heidi Carol,Harris Tegan Maree,Binks Michael John,Leach Amanda Jane

Funder

Centre for Research Excellence in Ear and Hearing Health of Aboriginal and Torres Strait Islander Children

NHMRC

GlaxoSmithKline

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. Non-typeable Haemophilus influenzae, an under-recognised pathogen;Van Eldere;Lancet Infect Dis,2014

2. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines;Leach;Int J Pediatr Otorhinolaryngol,2016

3. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine;Poolman;Vaccine,2000

4. Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae;Akkoyunlu;Infect Immun,1996

5. Distribution of protein D, an immunoglobulin D-binding protein, Haemophilus strains;Akkoyunlu;Infect Immun,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemophilus influenzae Protein D antibody suppression in a multi‐component vaccine formulation;FEBS Open Bio;2022-10-28

2. BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children;Frontiers in Pediatrics;2022-04-14

3. The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines;Expert Review of Vaccines;2022-02-22